Emergent BioSolutions Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Good afternoon, everybody, and thank you for joining Day 3 or Monday of the Morgan Stanley Global Healthcare Conference.
With me, I have Emergent. And before we get started, I'm going to read a quick disclaimer. For important disclosures, please see the Morgan Stanley Research Disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
So again, thanks for joining this fireside chat. I'm Albert Hwang. I'm a Managing Director and Co-Head of the U.S. Healthcare Group at Morgan Stanley in the Investment Banking division. And maybe what I'll do is turn it over to Rich Lindahl, the CFO of Emergent, to introduce the team. And perhaps, Rich, just to kick us off, you can give a 5-minute overview and update on what's going on at Emergent.
Great. Yes. Thanks, Albert. I appreciate it. And thank you, everyone,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
